Skip to main navigation

Top Navigation

About Us
- Our Company
- Contact Us
Our Pipeline
- Pipeline
  - ZN-c5
  - ZN-c3
  - ZN-d5
  - ZN-e4
- Clinical Trials
Our Approach
- Integrated Discovery Engine
- Supporting Publications
Investors & Media
Careers

Investors/Media

Press Releases

Press Releases

Year

Feb 25, 2021

Zentalis Pharmaceuticals and Tempus Announce Strategic Collaboration to Advance Research and Development Capabilities

Feb 24, 2021

Zentalis Pharmaceuticals to Present Initial Clinical Data on ZN-c3 at the AACR Annual Meeting 2021

Feb 10, 2021

Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors

Feb 05, 2021

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Jan 06, 2021

Zentalis Pharmaceuticals Announces the Initiation of Multiple Early-Stage Clinical Trials

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 15 of 15

Investors/Media

Investor Home
News & Events
- Press Releases
- Events & Presentations
Stock Information
Financials & Filings
- SEC Filings
Corporate Governance
Investor Resources

Investor Contact

Jain, Gitanjali
Solebury Trout
gogawa@soleburytrout.com

Media Contact

Julia Deutsch
Solebury Trout
jdeutsch@soleburytrout.com

“The sun is but a morning star.”

Corporate Office

530 Seventh Avenue
Suite 2201
New York, NY 10018

Science Center

10835 Road to the Cure
Suite 205
San Diego, CA 92121

For More Information

1-212-433-3791
info@zentalis.com

Footer

Privacy Policy
Terms of Use
Site Map

Copyright © 2021 Zentalis Pharmaceuticals. All Rights Reserved.